NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $386 | -16.3% | 31,394 | +9.5% | 0.00% | 0.0% |
Q2 2023 | $461 | -2.1% | 28,664 | +6.0% | 0.00% | 0.0% |
Q1 2023 | $471 | +292.5% | 27,043 | +107.9% | 0.00% | +200.0% |
Q4 2022 | $120 | -99.9% | 13,007 | -23.1% | 0.00% | 0.0% |
Q3 2022 | $146,000 | -0.7% | 16,904 | -6.3% | 0.00% | 0.0% |
Q2 2022 | $147,000 | -50.0% | 18,034 | -25.6% | 0.00% | -50.0% |
Q1 2022 | $294,000 | -61.5% | 24,235 | +8.3% | 0.00% | -33.3% |
Q4 2021 | $764,000 | -14.0% | 22,385 | +21.5% | 0.00% | -40.0% |
Q3 2021 | $888,000 | +45.8% | 18,417 | +36.6% | 0.01% | +66.7% |
Q2 2021 | $609,000 | +10.7% | 13,479 | +18.1% | 0.00% | 0.0% |
Q1 2021 | $550,000 | +9.8% | 11,414 | +22.7% | 0.00% | 0.0% |
Q4 2020 | $501,000 | +136.3% | 9,300 | +61.9% | 0.00% | +200.0% |
Q3 2020 | $212,000 | +32.5% | 5,745 | -53.0% | 0.00% | 0.0% |
Q2 2018 | $160,000 | +48.1% | 12,229 | -7.7% | 0.00% | 0.0% |
Q1 2018 | $108,000 | -40.7% | 13,250 | -35.3% | 0.00% | 0.0% |
Q4 2017 | $182,000 | +175.8% | 20,490 | +150.5% | 0.00% | – |
Q2 2016 | $66,000 | – | 8,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |